Lakeside Advisors’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
FWIA
GAM
Lakeside Advisors's MDT Position: Q2 2026 in Review
Lakeside Advisors reduced its Medtronic (MDT) stake by 2.5% in Q2 2026, selling an estimated $23.6K and leaving 11,568 shares worth $905K. The position accounts for 0.57% of the portfolio, ranked #34.
Lakeside Advisors first reported a position in MDT in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.56M in Q2 2023. 1,163 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Lakeside Advisors held 11,568 shares of Medtronic worth $905K as of Q2 2026.
- Lakeside Advisors sold 292 Medtronic shares in Q2 2026, an estimated $23.6K.
- Medtronic made up 0.57% of Lakeside Advisors's portfolio in Q2 2026, its #34 holding.
- Lakeside Advisors first reported a position in Medtronic in Q2 2022 and has held it in 17 quarters since.
- Lakeside Advisors's Medtronic position peaked at $1.56M in Q2 2023.
- 1,163 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Lakeside Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.